Division News

Dr. Nicole DePasquale recently received a K01 Career Development Award from the National Institute on Aging (NIA)

The April 13, 2021 session of Duke Medicine LEADS featured a discussion led by Kim Darlington, MD, PhD; Vinay Choksi, MD; and Neha Kayastha, MD, "Oh, Rats! Another Case of Encephalopathy"

Panelist included, Eileen Maziarz, MD; Matthew Luedke, MD, FACNS; and Xunrong Luo, MD, PhD, who weighed in for the diagnostic reasoning discussion.

Cameron Wolfe, MBBS, associate professor of medicine, and Thomas Holland, MD, associate professor of medicine, both in the Division of Infectious Diseases, are recipients of the Duke University Presidential Award for 2020.

The Feb. 16, 2021 session of Duke Medicine LEADS featured a discussion led by Yolanda Guzman, MD; Matthew Harbrecht, MD; and Jonathan Komisar, MD, "71-year-old male with dizziness, nausea, and difficulty walking."

Expert consultants included, Christopher Eckstein, MD; Thomas Holland, MD; and Neal Ready, MD, PhD, who weighed in for the diagnostic reasoning and discussion. 

The School of Medicine Office for Faculty Development has announced the 2021 participants in its ALICE program, a yearlong leadership development program for mid-career women faculty in leadership roles.

14 faculty from the Department of Medicine have been selected for the School of Medicine Office for Faculty's 2021 LEADER program.

The Dec. 8, 2020 session of Duke Medicine LEADS featured a case presentation by Trent Wei, MD; Lonnie Sullivan, MD; and Stacy Bagrova, MD, "26-year-old male with syncope and fevers", with expert consults Lance Okeke, MD, MPH; Chet Patel, MD; and John Carney, MD.

Five faculty from the Department of Medicine Division of Infectious Diseases are among 181 physicians and scientists elected as Fellows of the Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society. 

A warm welcome to new Department of Medicine faculty members who started in November 2020!

New studies are underway at Duke to test treatments that could help people with COVID-19 recover faster and avoid being hospitalized.

“The goal of interventional outpatient studies is to see if we can prevent people from developing more severe COVID disease requiring hospitalization,” says Susanna Naggie, MD, associate professor of medicine (Infectious Diseases) and vice dean for clinical research in the Duke University School of Medicine.